Allison Schwartz - 26 Apr 2022 Form 3 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
Director
Signature
/s/ Allison Schwartz
Issuer symbol
BIO
Transactions as of
26 Apr 2022
Net transactions value
$0
Form type
3
Filing time
28 Apr 2022, 18:24:01 UTC
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BIO Bio-Rad A Common Stock 856 26 Apr 2022 Direct
holding BIO Bio-Rad B Common Stock 3,848 26 Apr 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BIO Restricted Stock Units 26 Apr 2022 Bio-Rad A Common Stock 80 $0.000000 Direct F1, F6
holding BIO Restricted Stock Units 26 Apr 2022 Bio-Rad A Common Stock 164 $0.000000 Direct F2, F6
holding BIO Restricted Stock Units 26 Apr 2022 Bio-Rad A Common Stock 168 $0.000000 Direct F3, F6
holding BIO Restricted Stock Units 26 Apr 2022 Bio-Rad A Common Stock 131 $0.000000 Direct F4, F6
holding BIO Restricted Stock Units 26 Apr 2022 Bio-Rad A Common Stock 122 $0.000000 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 5, 2017, the reporting person was granted 400 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F2 On September 4, 2018, the reporting person was granted 410 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F3 On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F4 On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5 On September 1, 2021, the reporting person was granted 122 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.